Essex Bio-Technology

About Essex Bio-Technology

Essex Bio-Technology is a bio-pharmaceutical company that develops, manufactures and commercialises genetically engineered therapeutic Fibroblast Growth Factors (FGFs). Since 1998, they have had six flagship biologics approved for use in ophthalmology, dermatology and wound healing. Their products are available in more than 12,000 hospitals through direct sales, marketing and distribution centres in Asia. Essex Bio-Technology maintains a pipeline of research programmes in various clinical stages, covering a wide range of fields and indications. With four research sites globally, the company leverages its in-house R&D expertise and platform in growth factors (i.e. FGF2) and antibodies to maintain a pipeline of research projects in various clinical stages, covering a wide range of fields and indications.